Codes / ICD10CM / D56.5

D56.5 Hemoglobin E-beta thalassemia

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Hemoglobin E-beta thalassemia

Summary

Hemoglobin E-beta thalassemia is a genetic blood disorder resulting from the combination of hemoglobin E (HbE) and beta thalassemia mutations. This condition leads to reduced hemoglobin production, causing anemia and abnormal red blood cell formation. The severity varies, with symptoms ranging from mild to severe, depending on the specific genetic mutations and their impact on hemoglobin synthesis.

Causes

Hemoglobin E-beta thalassemia is caused by inherited genetic mutations in the HBB gene (for beta thalassemia) and the HBB gene (for hemoglobin E). These mutations are passed from parents to children in an autosomal recessive pattern, meaning an individual must inherit two defective genes (one from each parent) to develop the condition. The combination of these mutations disrupts normal hemoglobin production, leading to the disorder.

Risk Factors

  • Family history of hemoglobin E-beta thalassemia or related blood disorders
  • Ethnic background (more common in Southeast Asian populations, particularly in regions like Thailand, Laos, and Cambodia)
  • Consanguineous relationships

Symptoms

  • Fatigue
  • Pale skin
  • Jaundice
  • Enlarged spleen (splenomegaly)
  • In severe cases: swelling, heart problems, or growth delays

Diagnosis

Diagnosis involves blood tests to assess hemoglobin levels and red blood cell characteristics. Hemoglobin electrophoresis or DNA testing may confirm the specific genetic mutations. Prenatal testing is available for at-risk pregnancies.

Treatment Options

Treatment depends on severity and may include blood transfusions, iron chelation therapy, folic acid supplements, and in severe cases, bone marrow transplantation. Regular monitoring by a hematologist is essential.

Prognosis and Follow-Up

Prognosis varies based on severity. Mild cases may require minimal intervention, while severe cases need ongoing management. Regular follow-up with a hematologist is crucial to monitor complications and adjust treatment as needed.

Complications

  • Iron overload (from frequent transfusions)
  • Organ damage (e.g., liver, heart)
  • Growth delays
  • Increased risk of infections

Lifestyle & Prevention

  • Maintain a balanced diet rich in iron and folic acid
  • Avoid excessive alcohol consumption
  • Stay hydrated and manage stress
  • Genetic counseling for at-risk families

When to Seek Professional Help

Seek medical attention if experiencing persistent fatigue, jaundice, or unexplained swelling. Prompt evaluation is important for early diagnosis and management.

Tips for Medical Coders

Document the specific genetic mutations (HbE and beta thalassemia) and clinical severity to support accurate coding. Ensure documentation aligns with ICD-10-CM guidelines for D56.5, including any associated complications or treatment details.

Medical Policies and Guidelines

Related policies from health plans

Reblozyl (luspatercept)
Book a walkthrough

D56.5 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.